|
CN112225801A
|
|
Nanobodies and uses thereof
|
|
CN112225803A
|
|
Nanobodies and uses thereof
|
|
CN112250761A
|
|
Nanobodies and uses thereof
|
|
CN112225805A
|
|
Nanobodies and uses thereof
|
|
CN112225804A
|
|
Nanobodies and uses thereof
|
|
CN112225802A
|
|
Nanobodies and uses thereof
|
|
CN112225800A
|
|
Nanobodies and uses thereof
|
|
CN110358802A
|
|
A kind of endotoxic method of removal pertussis component pilin 2/3
|
|
CN110548135A
|
|
Phosphorylated polypeptide antigen vaccine and preparation method and application thereof
|
|
CN108676084A
|
|
The trim of Exenatide and its application
|
|
CN107952069A
|
|
Recombinant vaccine and its application
|
|
CN106880630A
|
|
Retro‑2cyclAnd the purposes of related derivatives
|
|
CN105968213A
|
|
Streptococcus pneumonia fusion protein and vaccine thereof
|
|
CN105367632A
|
|
Two staphylococcus aureus protein antigens and preparation method and use thereof
|
|
CN105198971A
|
|
Synthetic polypeptide and application thereof, and anti-influenza-virus vaccine
|
|
CN105131093A
|
|
Streptococcus pneumonia protein antigen, preparation therefor and applications
|
|
CN107034198A
|
|
A kind of chimeric norovirus P particles and its preparation and application
|
|
CN104984357A
|
|
Vaccine protective agent composition without gelatin and flu attenuated live vaccine
|
|
CN105018435A
|
|
Purifying method for virus-like particle
|
|
CN104788544A
|
|
Enterovirus 71 type epitope as well as antibody and application and vaccine thereof
|
